In addition to Luminex bead-based multiplex assays and Olink assays as a broad initial analysis for biomarker profiling,
our high-precision multiplex assays are established upon MSD-ECL (Meso Scale Diagnostics-Electrochemiluminescence)
technology platform to detect biomarkers difficult or impossible to measure with conventional assays. The Electrochemiluminescence
nature of the ultra-sensitive MSD technology allows an average of 100x sensitivity increase over Luminex assays with CVs <10%.
We provide the most cost-effective high-precision multiplex testing services on MSD-ECL technology platform to
measure the following biomarkers with quality assurance and capability of custom assay development:
